What is Ampronix?
Established in 1982, Ampronix operates as a premier authorized master distributor and manufacturer of high-end medical technology. The company distinguishes itself through a comprehensive service model that integrates product distribution with a state-of-the-art repair facility. By maintaining rigorous quality standards, including ISO 13485:2003 and ISO 9001:2008 certifications, Ampronix provides tailored, cost-effective solutions that address the complex requirements of modern healthcare providers. Its unique position as a one-stop provider allows it to bridge the gap between original equipment manufacturers and clinical end-users, ensuring seamless integration of critical medical hardware.
How much funding has Ampronix raised?
Ampronix has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Ampronix
PPP
Public-Private Partnership
What's next for Ampronix?
Following this late-stage financing, Ampronix is expected to prioritize the scaling of its proprietary manufacturing lines and the enhancement of its technical support infrastructure. The strategic allocation of these funds will likely focus on optimizing supply chain efficiencies and expanding the reach of its repair services to meet the increasing demand for reliable medical equipment maintenance. As the healthcare industry continues to prioritize technological resilience, Ampronix is poised to capitalize on its deep domain expertise to capture additional market share and solidify its role as an essential partner in the medical device ecosystem.
See full Ampronix company page
